Therapeutic targeting of FZD receptor proteins with biologics in cancer.
1/5 보강
Wnt signaling plays key roles in the initiation, progression, and therapy resistance of various cancers.
APA
Hmila I, Katanaev VL (2026). Therapeutic targeting of FZD receptor proteins with biologics in cancer.. Drug discovery today, 31(2), 104621. https://doi.org/10.1016/j.drudis.2026.104621
MLA
Hmila I, et al.. "Therapeutic targeting of FZD receptor proteins with biologics in cancer.." Drug discovery today, vol. 31, no. 2, 2026, pp. 104621.
PMID
41655894 ↗
Abstract 한글 요약
Wnt signaling plays key roles in the initiation, progression, and therapy resistance of various cancers. No drugs targeting this pathway are currently available, and several candidates have failed because they affected healthy tissues such as bone and intestine. It is necessary, therefore, to develop efficient and safe Wnt pathway inhibitors that act selectively on tumors. The targeting of individual FZD receptor proteins that initiate Wnt pathways is a promising approach to the development of selective inhibitors. In this review, we summarize the physiological and pathological roles of each of ten FZDs and describe diverse selective biologics that have been developed to target them. Antibodies, designer proteins, peptides, nanobodies, and aptamers are being studied for their potential as selective, efficient, and safe anti-Wnt treatments that could be used to combat specific cancers and other pathologies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.